Nivolumab Plus Cisplatin/Pemetrexed or Cisplatin/Gemcitabine as Induction in Resectable Non-Small Cell Lung Cancer

Clinical trial NCT03366766 · TERMINATED

Trial details

NCT number: NCT03366766
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Non-Squamous Non-Small Cell Lung Carcinoma Stage I Non-Small Cell Lung Cancer Stage IA Non-Small Cell Lung Carcinoma Stage IB Non-Small Cell Lung Carcinoma Stage II Non-Small Cell Lung Cancer Stage IIA Non-Small Cell Lung Carcinoma Stage IIB Non-Small Cell Lung Carcinoma Stage IIIA Non-Small Cell Lung Cancer

Start date: 2017-12-20
Primary completion: 2020-12-06
Enrollment: 14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.